You will very likely experience increased hunger during weeks two through four after switching
In addition, more participants in the L-carnitine group became pregnant than those who took placebo, and they had fewer miscarriages
Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, et al
Journal of the American Chemical Society #GLP1 #Retatrutide #Obesity #MetabolicHealth #WeightLoss #HormoneTherapy #PrecisionMedicine #PersonalizedMedicine #Diabetes #ClinicalTrials #Biotech #Peptides To view or add a comment, sign in More Relevant Posts This weeks Metabolic Weekly Update highlights how obesity care is moving beyond single pathwaystoward multi-target drugs, oral therapies, and deeper links between metabolic, liver, and brain health
For patients who struggled with nausea on tirzepatide or semaglutide, the slower schedule is often the better choice
What actually excites me is the oral formulation